The pristine samples from asteroid Ryugu returned by the Hayabusa2 mission on December 6, 2020, have been vital to improving ...

AI is reshaping GRC, demanding a new kind of archetype — forward-operating professionals who don't just manage governance; ...

Osteoarthritis drug developer Paradigm says its purchase of an oral drug candidate won't distract it from its key phase III knee trial.

Despite major advances, real-world data show diminishing survival outcomes and treatment-limiting toxicities in second line ...

Kalshi raises $185M at $2B valuation, signaling prediction market maturity and crypto sector growth amid regulatory challenges.

A new DEX called GTE has received funding support to beat the existing CEXs and DEXs using its CLOB model. Can it overcome ...

GTE raised $15M in Series A funding led by Paradigm, aiming to become the fastest decentralized exchange and rival major ...

The U.S. healthcare system—nearly a fifth of the nation’s GDP—faces mounting financial and operational stress, with dramatic ...

White House reacts after intel assessment contradicts Trump on Iran strikes What to Do with Pennies: Smart Uses for the Coins ...

House Republicans are demanding answers on U.S. readiness for drone attacks on the homeland, citing concerns about military ...

Paradigm has filed an amicus brief arguing the jury in the case against Tornado Cash co-founder Roman Storm needs clarity on ...

Targeted therapies and immunotherapy can provide benefits when added to chemotherapy or may eliminate the need for ...